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The mechanism by which lentivirus envelope (Env) glycoproteins are packaged into budding virions is poorly understood.
Simian immunodeficiency virus (SIV) contains an Env protein with an unusually long cytoplasmic tail. To investigate the role
of this domain in the incorporation of the SIV Env into virions, we generated a series of SIV Env mutants carrying small
in-frame deletions within the cytoplasmic domain. The effects of these mutations on Env synthesis, processing, and
association with Gag particles were analyzed by means of the vaccinia virus expression system. All of the mutant Env
glycoproteins were synthesized and processed in a manner similar to that of the wild-type Env. However, deletions affecting
domains C-terminal to residue 832 in the SIV Env protein significantly impaired Env incorporation into particles. Cell surface
biotinylation assays showed that this phenotype could not be attributed to inefficient cell surface expression of the Env
mutants. Furthermore, when the Env deletion mutants were tested for their ability to mediate virus entry in single-cycle
infectivity assays, those mutations that impaired Env incorporation also caused a severe defect in virus infectivity. Our results
suggest that domains in the C-terminal third of the SIV Env protein are required for Env incorporation into particles and
Env-mediated virus entry. © 2001 Academic PressINTRODUCTION
The formation of infectious retroviral particles involves
the incorporation of the viral envelope (Env) glycopro-
teins into the virions that are released by budding at the
plasma membrane. The Env glycoproteins of human and
simian immunodeficiency viruses (HIV and SIV, respec-
tively) are synthesized as a precursor that is proteolyti-
cally cleaved, most likely in the trans-Golgi network, by a
cellular protease during transport to the cell surface
(Hunter, 1997). Cleavage of the HIV/SIV Env precursor
yields the two components of the Env glycoprotein com-
plex: the surface (SU) glycoprotein gp120 and the trans-
membrane (TM) glycoprotein gp41. The SU–TM com-
plexes are then transported to the cell surface of the
infected cell where they are incorporated into the re-
leased virus particles by a mechanism that is still not
well understood.
In contrast to other retroviruses, the TM glycoprotein
of lentiviruses contains a long cytoplasmic domain of
approximately 150 to 200 amino acids (Hunter, 1997;
Hunter and Swanstrom, 1990). Several studies have at-
tempted to define the biological role of the TM cytoplas-
mic domain. For HIV and SIV, mutations in this region
have been shown to affect several properties of the Env
glycoproteins, including stability, proteolytic processing
1 To whom correspondence should be addressed. Fax: (54-11) 4856-
495. E-mail: sag@cevan.sld.ar or sagonza@hotmail.com.253(Johnston et al., 1993), glycosylation (Jowett and Jones,
1993), fusogenic capacity (Ashorn et al., 1990; Ritter et al.,
1993), and cell surface expression (LaBranche et al.,
1995; Sauter et al., 1996). The contribution of the TM
cytoplasmic domain to the process of Env incorporation
into virions has been addressed in a number of studies
that have yielded conflicting results. HIV-1 TM molecules
with truncated cytoplasmic tails have been shown to be
incorporated into particles (Gabuzda et al., 1992; Wilk et
al., 1992). However, other reports have provided evi-
dence for the requirement of an intact TM cytoplasmic
domain for Env association with virions (Dubay et al.,
1992; Murakami and Freed, 2000b; Yu et al., 1993). Fur-
thermore, the observation that the Env incorporation
block imposed by mutations in the HIV-1 and SIV matrix
(MA) domain of the Gag polyprotein can be reversed by
expression of an Env protein with a short TM cytoplasmic
tail (Freed and Martin, 1995, 1996; Gonza´lez et al., 1996;
Mammano et al., 1995) supports the notion that an inter-
action between the TM cytoplasmic tail and the MA
domain modulates Env incorporation into virions. More-
over, a physical interaction between the HIV-1 MA and
the TM cytoplasmic domain has recently been demon-
strated by using in vitro binding assays (Cosson, 1996).
The incorporation of the HIV/SIV Env glycoproteins into
virions is a key step in the viral replication cycle. In this
regard, identification of the amino acids in both the MA
protein and the TM cytoplasmic tail that through their
interactions drive Env incorporation into virions would be
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254 CELMA ET AL.useful for the rational design of antiviral strategies aimed
at blocking HIV and SIV infectivity.
In this report, we studied the effect of short in-frame
deletions within the SIV TM cytoplasmic domain on the
incorporation of the SIV Env protein into particles and on
virus infectivity. Deletions affecting the C-terminal third of
the SIV TM cytoplasmic tail were found to impair Env
incorporation into particles. Moreover, these SIV Env
mutants also appeared to be inefficient at mediating
virus entry in single-cycle infectivity assays.
RESULTS
Construction and characterization of SIV Env mutants
carrying in-frame deletions in the TM cytoplasmic
domain
To investigate the role of the SIV TM cytoplasmic tail in
Env incorporation into virions and virus infectivity, we first
generated a series of eight env gene constructs carrying
short in-frame deletions within the TM cytoplasmic tail
(Fig. 1). These deletions comprised the following amino
acids of the SIV Env glycoprotein: 798–802 (DE1); 808–
811 (DE2); 818–821 (DE3); 832–837 (DE4); 842–848 (DE5);
853–859 (DE6); 861–866 (DE7); and 870–874 (DE8). These
in-frame deletions target the two amphipathic a-helices
hat have been predicted from the env gene primary
FIG. 1. Construction of the SIV Env deletion mutants. Schematic diagra
in the TM cytoplasmic tail (CT). The SIV Env protein is depicted at the
SIV Env membrane-spanning domain is indicated by a shaded box. Regi
ndicate the length of each in-frame deletion. Amino acid residues areequence (Miller et al., 1993). The mutated SIV env genes iere used to generate recombinant vaccinia viruses
xpressing the mutated Env glycoproteins the phenotype
f which was then characterized. To determine whether
he in-frame deletions introduced into the SIV TM cyto-
lasmic domain had any effect on the synthesis and
rocessing of the Env glycoprotein, CV-1 cells were in-
ected in parallel with the recombinant vaccinia viruses
xpressing the wild-type Env or the Env mutants and
etabolically labeled with [35S]methionine/cysteine for
h. The Env-specific polypeptides were immunoprecipi-
ated from the cell lysates with pooled sera from SIV-
nfected macaques. All of the mutant Env glycoproteins
ere expressed at levels similar to those of the wild-type
nv and were found to be processed normally to the SU
nd TM subunits (Fig. 2).
ffect of the small in-frame deletions in the TM
ytoplasmic domain on Env incorporation into
articles
We have previously shown that coinfection of CV-1
ells with two recombinant vaccinia viruses expressing
he SIV Gag-protease (Gag-PR) precursor and the SIV
nv protein results in the assembly and release of virus-
ike particles carrying the viral Env glycoprotein (Gonza´-
ez et al., 1993). This system has also allowed us to
dentify an MA domain the mutation of which impairs Env
ild-type (WT) and mutant Env proteins carrying small in-frame deletions
wing the cleavage site between its SU and TM subunits (arrow). The
otential amphipathic a-helices are shown in black boxes. Parentheses
ered according to their position in the SIVSMMPBj Env protein.m of w
top sho
ons of p
numbncorporation into particles (Gonza´lez et al., 1996). We
255ROLE OF THE SIV gp41 CYTOPLASMIC TAIL IN Env INCORPORATIONtherefore exploited this recombinant system to deter-
mine whether the in-frame deletions in the TM cytoplas-
mic domain affected the ability of the mutated Env gly-
coproteins to associate with Gag particles. Cells were
coinfected with the recombinant vaccinia viruses ex-
pressing each of the SIV Env mutants together with that
expressing the SIV Gag-PR polyprotein, and the virus-like
particles released into the culture medium of the infected
cells were purified by ultracentrifugation through a su-
crose cushion (Gonza´lez et al., 1993). Cells coexpressing
wild-type Env and Gag-PR were included as a control.
The degree of Env incorporation into particles was eval-
uated by assessing the levels of particle-associated SIV
TM by Western blot analysis using an anti-SIV gp41
monoclonal antibody (MAb) (Fig. 3A). Immunoblot analy-
sis was carried out for the SIV TM protein instead of the
SU glycoprotein because the latter can be spontane-
ously shed from the cell surface of infected cells and
therefore may contaminate the particulate fraction. As
shown in Fig. 3A (right), the SIV Env mutants DE1 to DE3
were incorporated into particles at levels similar to or
even higher than those of wild-type Env. By contrast,
deletions DE4 to DE8 significantly reduced the incorpo-
ration levels of the SIV Env protein into particles. Of note,
the amounts of particle-associated DE4, DE7, and DE8
TM proteins were almost undetectable compared to
those of wild-type TM (Fig. 3A, right). In independent
experiments, low but detectable levels of particle-asso-
ciated Env protein were consistently observed for mu-
tants DE5 and DE6. When the cell lysates were analyzed
by imunoblotting with the same anti-SIV gp41 serum,
comparable amounts of wild-type TM and mutated TM
FIG. 2. Expression of wild-type and mutant SIV Env proteins by
recombinant vaccinia viruses. CV-1 cells infected with vaccinia viruses
expressing wild-type Env (WT) or mutants DE1 to DE8 were metaboli-
cally labeled with a [35S]methionine/cysteine mix for 4 h. Viral proteins
were immunoprecipitated from cell lysates and analyzed by SDS–
PAGE. The mobilities of the SIV Env precursor (Pre) and the surface
subunit (SU) are indicated. The positions of the protein size markers (in
kDa) are shown on the right.proteins were detected (Fig. 3A, left), ruling out the pos-sibility that the incorporation-defective phenotype exhib-
ited by mutants DE4 to DE8 was due to inefficient intra-
cellular expression. Moreover, the inhibition of SIV Env
incorporation into particles caused by deletions DE4 to
DE8 could not be attributed to inefficient release of
virus-like particles since similar amounts of SIV Gag
proteins were detected in all particulate fraction samples
(Fig. 3B, right).
Cell surface expression of the SIV Env glycoproteins
carrying deletions within the cytoplasmic domain
To determine whether the incorporation-defective phe-
notype exhibited by the mutated Env glycoproteins DE4
to DE8 could be explained by reduced cell surface ex-
pression, the relative levels of each of these Env mutants
on the surface of infected cells were compared to the
levels of the wild-type Env. After performing cell surface
biotinylation of metabolically labeled cells expressing
either wild-type Env or mutant DE4, DE5, DE6, DE7, or
DE8, the Env glycoproteins were first immunoprecipi-
tated from each cell lysate and then transferred to nitro-
cellulose membranes. Those Env glycoproteins that had
been exposed to the biotinylation reagent on the cell
surface were visualized by using streptavidin-conjugated
horseradish peroxidase and enhanced chemilumines-
cence (Fig. 4). As described in previous studies using
similar biotinylation assays, both the Env precursor and
the SU proteins were detected at the cell surface (Fig. 4)
FIG. 3. Effect of deletions in the SIV TM cytoplasmic tail on the
incorporation of Env into particles. CV-1 cells were coinfected with a
vaccinia virus recombinant expressing the SIV Gag-PR polyprotein and
a vaccinia recombinant expressing either the wild-type Env (WT) or
each of the SIV Env mutants (DE1 to DE8). At 24 h.p.i., cells were
harvested and virus-like particles were purified from the clarified cul-
ture supernatants. Viral proteins from cell lysates (cells) and virus-like
particles (particles) were detected by Western blotting using either an
anti-gp41 MAb (A) or an anti-p27 MAb (B). The positions of the TM
proteins as well as that of the Gag precursor and its processed product
(capsid, CA) are shown.
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256 CELMA ET AL.(Salzwedel et al., 1999; Spies and Compans, 1994). As
shown in Fig. 4, all of the incorporation-defective Env
mutants were expressed on the cell surface at levels
similar to those of the wild-type Env. To control for bioti-
nylation of only glycoproteins that were expressed on the
cell surface, we included cells expressing rotavirus VP7
glycoprotein, an endoplasmic reticulum membrane pro-
tein. No rotavirus VP7 was observed on the cell surface
by the biotin–streptavidin reaction, although it was effi-
ciently expressed intracellularly, as evidenced by immu-
noprecipitation of the 35S-labeled cell lysates (Fig. 4,
right; compare lanes S and L).
Effect of in-frame deletions in the SIV TM
cytoplasmic domain on virus entry
To evaluate the impact of all the mutations introduced
in the SIV TM cytoplasmic tail on virus entry, we used the
single-cycle infectivity assay in which an env-deficient
provirus is complemented by an Env protein expressed
in trans (Kimpton and Emerman, 1992). The resulting
virus is then used to infect MAGI indicator cells in order
to assess its infectivity by counting blue cells after in situ
staining with X-Gal. It has been demonstrated that the
FIG. 4. Analysis of cell surface SIV Env expression. Cells expressing
ild-type Env (lane 1) or Env mutants DE4, DE5, DE6, DE7, or DE8
lanes 2 to 6) were metabolically labeled with a [35S]methionine/cys-
teine mix and biotinylated at 4°C as described under Materials and
Methods. Env proteins immunoprecipitated from whole-cell lysates
were separated by SDS–PAGE (7.5% polyacrylamide) and transferred to
a nitrocellulose membrane. Proteins on the cell surface were visualized
by using streptavidin-conjugated horseradish peroxidase coupled with
enhanced chemiluminescence (top). Total cellular Env expression was
detected by autoradiography of the 35S-labeled immunoprecipitated
material (bottom). To control for biotinylation of only cell surface pro-
teins, cells expressing rotavirus VP7 were included in a parallel exper-
iment and subjected to metabolic labeling and biotinylation as de-
scribed above (right). S, detection of cell surface proteins by the
biotin–streptavidin reaction in cells expressing rotavirus VP7; L, total
cellular expression of rotavirus VP7.SIV Env glycoprotein can efficiently complement HIV-1entry into susceptible target cells (Johnston et al., 1993;
ingler and Littman, 1993). Therefore, the ability of SIV
nv glycoproteins to mediate virus entry can be esti-
ated by means of this assay (Johnston et al., 1993;
ingler and Littman, 1993). All the mutated SIV env gene
onstructs were subcloned into a CMV promoter-based
xpression vector and used to generate pseudotypes of
n env-minus pNL4-3 derivative with each of the Env
utants. HIV-1 virions pseudotyped with the SIV Env
utants were obtained by cotransfecting 293T cells with
he expression vectors for each Env protein and the
nv-minus pNL4-3. Equivalent amounts of the
seudotyped viruses, as determined by reverse tran-
criptase activity measurement, were then used to infect
AGI-CCR5 cells. This allowed us to readily quantitate
he effect of the Env mutations on Env-mediated virus
ntry. The results obtained in this assay indicated that
he ability of the Env deletion mutants DE1 to DE8 to
ediate virus entry correlated with the Env incorporation
henotype obtained in the vaccinia system. Indeed, mu-
ants DE1 to DE3, which were incorporated into particles
in a wild-type manner, were as efficient as the wild-type
Env at mediating virus entry (Fig. 5). By contrast, those
in-frame deletions that caused an incorporation-defec-
tive phenotype were also found to impair virus infectivity
(Fig. 5). Env deletions DE4 and DE8 produced the most
drastic effect on virus infectivity: 25-fold and 10-fold re-
ductions in virus infectivity for DE4 and DE8 respectively,
ith respect to wild-type values. Indeed, virions
seudotyped with Env mutants DE4 and DE8 displayed
nfectiviites of 3.8 6 0.4% and 7.8 6 3.0%, respectively,
ompared to that of virions pseudotyped with the wild-
ype Env. Mutants DE6 and DE7 were also very inefficient
t mediating virus entry (relative infectivities of 24.2 6
.8% and 15.0 6 5.6%, respectively, of the wild-type
alue), whereas mutant DE5 yielded approximately
1% of the wild-type level of entry (relative infectivity of
1.5 6 2.6%).
The characterization of Env mutants DE1 to DE8
ointed to a critical role played by the C-terminal third
egion of the SIV TM cytoplasmic domain in both Env
ncorporation into particles and virus infectivity. However,
he possibility existed that domains within the N-terminal
hird of the SIV TM cytoplasmic tail might also contribute
o these processes. To this end, we generated a set of
dditional in-frame deletion Env mutants affecting resi-
ues that are located amino-terminal to mutation DE1.
The membrane proximal region of the SIV TM cytoplas-
mic domain was not subjected to mutagenesis because
this domain has been shown to regulate Env surface
expression (Sauter et al., 1996). The deletions involved
the following amino acids in the SIV Env glycoprotein:
763–767 (DE9), 772–774 (DE10), 778–782 (DE11), and
789–794 (DE12). The effect of these deletions on virus
infectivity was tested in the single-cycle infectivity MAGI
assay. As shown in Fig. 6, all these Env mutants medi-
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257ROLE OF THE SIV gp41 CYTOPLASMIC TAIL IN Env INCORPORATIONated virus entry with an efficiency similar to or higher
than that of the wild-type Env. These Env mutants were
also found to be incorporated into particles in a wild-type
manner (data not shown). These results indicate that the
domains targeted by deletions DE9 to DE12 are dispens-
able for incorporation of the SIV Env into virions and virus
infectivity.
DISCUSSION
The HIV and SIV Env proteins are involved in functions
that are critical for viral replication and pathogenesis and
are also targets of immune responses. In this study, we
investigated the role of the long cytoplasmic tail of the
SIV Env glycoprotein in Env incorporation and virus in-
fectivity. We constructed and characterized the pheno-
type of 12 SIV Env mutants bearing in-frame deletions
within the TM cytoplasmic domain. Deletions introduced
within the N-terminal and central domains of the SIV TM
cytoplasmic tail had no effect on Env association with
particles or on virus infectivity. In contrast, deletions that
affected domains in the C-terminal third of the TM cyto-
plasmic tail (DE4 to DE8) significantly impaired Env in-
corporation into particles without affecting Env protein
synthesis, processing, or cell surface expression. More-
over, mutants DE4, DE7, and DE8 were highly inefficient
at mediating virus entry.
HIV and SIV particles must accomodate Env glycopro-
teins with long cytoplasmic tails. Increasing evidence
FIG. 5. MAGI infectivities of HIV-1 virions pseudotyped with wild-typ
NL4-3 and the expression plasmids for either wild-type (wt) Env or e
normalized for RT activity and the ability of the Env proteins to mediate
Two days postinfection, MAGI-CCR5 cells were stained with X-Gal and
quantitated as the total number of blue cells obtained by infection with v
of blue cells obtained upon infection of wtEnv-pseudotyped viruses (consindicates that specific interactions between the MA pro- stein and the TM cytoplasmic domain mediate Env incor-
poration into virions. Such interactions are supported by
the following data: (i) Coexpression of the SIV MA and
Env proteins has been shown to result in the assembly
and release of lentivirus-like particles that incorporate
the Env protein (Gonza´lez et al., 1993); (ii) mutations in
the MA domain of both HIV-1 and SIV Gag polyproteins
impair Env incorporation into particles (Dorfman et al.,
1994; Freed and Martin, 1995, 1996; Gonza´lez et al., 1996;
Lee et al., 1997; Yu et al., 1992); (iii) a single amino acid
change in the MA domain of the HIV-1 Gag precursor can
reverse the Env incorporation and infectivity defect im-
posed by a small deletion in the HIV-1 gp41 cytoplasmic
tail (Murakami and Freed, 2000a); (iv) a MAb specific to
the SIV Gag is able to coimmunoprecipitate Gag and Env
proteins from saponin-permeabilized cells (Vincent et al.,
1999); (v) a direct interaction between the HIV-1 Env
cytoplasmic domain and the MA protein has been dem-
onstrated by using an in vitro binding assay (Cosson,
996).
Thus, it could be speculated that the C-terminal in-
rame deletions DE4 to DE8 may interfere with the Env–
ag interactions that are necessary for the incorporation
f the Env protein into particles. These small deletions in
he SIV TM protein may remove critical amino acids
equired for Env–Gag association. Alternatively, since
here is currently no structural information on the folding
f the SIV TM cytoplasmic tail, it cannot be ruled out that
v mutants DE1 to DE8. 293T cells were cotransfected with env-minus
the SIV Env mutants DE1 to DE8. The pseudotyped virus stocks were
ntry was determined by the MAGI assay (see Materials and Methods).
mbers of blue foci were quantitated microscopically. Virus entry was
seudotyped with each SIV Env mutant and referred to the total number
as 100%). Data presented are averages of at least three assays 6 SD.e or En
ach of
virus e
the nu
iruses pome of the mutations DE4 to DE8 may cause local
a258 CELMA ET AL.structural perturbations that may alter the accessibility of
the TM residues that participate in the interaction with
the Gag polyprotein. The involvement of host cell-derived
proteins in facilitating Gag–Env interactions is another
factor that may be invoked to explain the phenotype
exhibited by mutants DE4 to DE8. Some of these muta-
tions may prevent recruitment by the SIV TM of as-yet-
unknown cellular factors that modulate Env packaging
into virions. In this regard, cell type-specific differences
in the incorporation into virions of a truncated version of
the HIV-1 Env lacking most of the cytoplasmic tail (Mu-
rakami and Freed, 2000b) have been observed recently,
a finding that suggests that cellular factors may play a
role in Env packaging into virions. Our finding that do-
mains within the C-terminal third of the SIV TM cytoplas-
mic tail are necessary for Env incorporation is in keeping
with data from in vitro binding assays indicating that the
region of the HIV-1 Env protein involved in interactions
with MA comprises the C-terminal 67 amino acid resi-
dues of Env (Cosson, 1996). Moreover, we have recently
generated a series of SIV Env truncation mutants in
which the TM cytoplasmic tail was progressively short-
ened from its C-terminus by 20 amino acids and have
found that removal of from 20 up to 100 residues abro-
gates Env incorporation into particles (Manrique et al.,
unpublished data).
It has been observed that truncated SIV Env glyco-
FIG. 6. Ability of the SIV Env mutants DE9 to DE12 to mediate virus en
plasmids for either wild-type (wt)Env or SIV Env mutants DE9 to DE12. Th
the Hela-CD4-CCR5/LTR-b-gal cell line. Virus entry was quantitated as d
ssays 6 SD.proteins bearing an 18-amino-acid-long cytoplasmic tailare incorporated into virions (Zingler and Littman, 1993;
Vzorov and Compans, 1996). However, the mechanism
by which these mutant Env proteins with short cytoplas-
mic domains are incorporated into particles appears to
be different from that mediating the incorporation of
wild-type proteins with long cytoplasmic tails. Indeed, we
have demonstrated that an SIV Env glycoprotein with a
short cytoplasmic tail is incorporated into particles in an
MA-independent manner (Gonza´lez et al., 1996). Similar
evidence has been obtained in HIV-1 (Freed and Martin,
1995; Mammano et al., 1995). It is therefore likely that Env
proteins with short cytoplasmic tails avoid the steric
constraints imposed by the particle structure as well as
the protein–protein interactions that normally modulate
the packaging of the wild-type Env proteins into virions.
In support of this notion, several studies have reported
that HIV-1 particles can incorporate distantly related ret-
roviral glycoproteins, provided that they bear a short
cytoplasmic tail (Kimpton and Emerman, 1992; Mam-
mano et al., 1995).
In conclusion, our mutagenesis analysis of the SIV TM
cytoplasmic tail assigns an important role to the C-
terminal third of this domain in the process of Env incor-
poration into virions. This may provide an explanation for
the presence and maintenance of a long cytoplasmic tail
in the SIV Env glycoprotein. Moreover, knowledge of the
domains in the SIV TM cytoplasmic tail involved in the
T cells were cotransfected with env-minus pNL4-3 and the expression
dotyped HIV-1 virions were normalized for RT activity and used to infect
ed in the legend to Fig. 5. Data presented are averages of at least threetry. 293
e pseu
escribincorporation of the Env glycoprotein into particles will
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259ROLE OF THE SIV gp41 CYTOPLASMIC TAIL IN Env INCORPORATIONbe useful for the design of experiments aimed at eluci-
dating the molecular mechanism underlying this pro-
cess.
MATERIALS AND METHODS
Cells and viruses
African green monkey kidney (CV-1) cells and rat em-
bryo (Rat2) TK2 cells, grown in Dulbecco’s modified Ea-
gle’s medium (DMEM; GIBCO BRL) supplemented with
10% fetal bovine serum, were used to establish recom-
binant vaccinia viruses. The parental vaccinia virus used
for generating the recombinant viruses was the WR
strain. 293T cells (obtained from the American Type Cul-
ture Collection) and MAGI-CCR5 (HeLa-CD4-CCR5/LTR-
b-gal) cells were grown in DMEM containing 10% fetal
bovine serum. MAGI-CCR5 were additionally maintained
in medium containing 0.2 mg/ml G418 (geneticin), 0.1
mg/ml hygromycin B, and 1 mg/ml puromycin as recom-
ended by the contributor (Chackerian et al., 1997). The
MAGI-CCR5 cell line was obtained through the NIH AIDS
Research and Reference Reagent Program, Division of
AIDS, National Institute of Allergy and Infectious Dis-
eases, and was originally contributed by Julie Over-
baugh.
MAbs and antisera
The MAbs used to detect SIV Gag-related proteins
p55/p27 (KK60) and SIV gp41 (KK41) (Kent et al., 1992)
were obtained from Jim Stott and Karen Kent through the
MRC AIDS Directed Programme. Pooled antisera from a
SIVSMMPBj-infected macaque was provided by P. N. Fultz
(University of Alabama at Birmingham).
Construction of mutated SIV env genes
All SIV sequences are derived from the SIVSMM PBj14
irus isolate (proviral clone PBj1.9) (Dewhurst et al.,
990). Construction of a plasmid directing the synthesis
f the SIV Env glycoprotein precursor has been de-
cribed before (Gonza´lez et al., 1994). The small in-frame
eletion mutations in the coding region of the SIV TM
ytoplasmic tail were introduced by asymmetric PCR-
ased site-directed mutagenesis as described previ-
usly (Gonza´lez et al., 1993) using Elongase Enzyme Mix
GIBCO BRL). For the construction of mutants DE1 to
E8, mutagenesis was performed on a BglII/SphI restric-
ion fragment that corresponds to nucleotides 8673–9034
n the PBj1.9 env gene. To generate the set of env mu-
ants DE9 to DE12, mutagenesis was carried out on a
scI/SphI fragment (nucleotides 8264 to 9034). The
glII/SphI or MscI/SphI fragments carrying the desired
utations were substituted for the wild-type counter-
arts in a pUC19 vector containing the SIV wild-type env
ene. All mutated constructs were sequenced to confirmhe presence of the corresponding in-frame deletions inhe PBj1.9 env gene. The mutated env sequences were
hen excised from the pUC19 vector by digestion with
pnI and SphI restriction enzymes and subcloned into
he corresponding sites in pULB5212, a pSC11-derived
accinia transfer vector (Chakrabarti et al., 1985). For the
AGI assays, the mutated env genes were subcloned
nto pCDNA3.1(1) (Invitrogen).
eneration of recombinant vaccinia viruses
Generation, selection, and purification of recombinant
accinia viruses were performed as described previously
Gonza´lez et al., 1993). Several independent recombinant
accinia viruses for each mutant were initially screened
o ensure that their env products exhibited the same
henotype.
rotein expression and metabolic labeling
Confluent monolayers of CV-1 cells (35-mm-diameter
etri dishes) were infected with the recombinant vac-
inia viruses at a multiplicity of infection of 5 PFU per
ell. At 14 h postinfection (h.p.i), the medium was
hanged to methionine- and cysteine-deficient DMEM
ICN Biomedicals, Inc.) supplemented with 3% fetal bo-
ine serum containing 100 mCi/ml of a [35S]methionine/
cysteine mix (.1000 Ci/mmol; Easytag EXPRESS Protein
Labeling Mix, NEN), and cells were radiolabeled for 4 h.
Metabolically labeled cells were washed with cold phos-
phate-buffered saline (PBS) and lysed at 4°C in 100 ml
NN lysis buffer [50 mM Tris–HCl (pH 8.0), 150 mM NaCl,
% Nonidet P-40, 1 mM phenylmethylsulfonyl fluoride,
nd 10 mg/ml of aprotinin). The postnuclear supernatants
were subjected to immunoprecipitation with pooled sera
from an SIV-infected macaque and analyzed by SDS-
polyacrylamide gel electrophoresis (SDS–PAGE) and au-
toradiography as described previously (Gonza´lez and
Affranchino, 1995).
Western blot analysis
CV-1 cells grown in 100-mm-diameter dishes were
coinfected with each Env mutant and a vaccinia recom-
binant expressing the SIVSMMPBj Gag-PR polyprotein
Gonza´lez et al., 1993) at a multiplicity of infection of 5
FU per cell of each virus. Cells were harvested at 23–24
.p.i. and lysed in 300 ml TNN buffer. Virus-like particles
were purified from the clarified cell supernatants by
ultracentrifugation (100,000 g, 90 min at 4°C) through a
20% (w/v) sucrose cushion and then lysed in Laemmli
buffer (Laemmli, 1970). Equal volumes of cell or particle
lysates were resolved by SDS-PAGE, blotted onto nitro-
cellulose membranes (Hybond ECL, Amersham Pharma-
cia Biotech), and analyzed by Western blotting coupled
with an enhanced chemiluminescence assay (ECL, Am-
ersham Pharmacia Biotech). In some cases, blots were
stripped according to the manufacturer’s instructions
and reprobed with another MAb.
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CV-1 cells grown in 60-mm-diameter dishes were in-
fected with each Env mutant as described above. At
14 h.p.i., infected cells were pulse-labeled in methio-
nine–cysteine-free DMEM supplemented with [35S]methi-
onine/cysteine mix (250 mCi/ml) for 20 min and then
chased in complete DMEM for 2 h. Following the pulse-
chase radiolabeling step, the infected CV-1 cells were
rinsed three times in ice-cold PBS and were then incu-
bated for 30 min with the membrane-impermeable bioti-
nylating reagent biotinamidocaproate N-hydroxysucci-
namide ester in 40 mM sodium bicarbonate buffer (pH
8.6) (ECL Protein Biotinylation System; Amersham Phar-
macia Biotech) at 4°C. The reaction was quenched by
washing the cell monolayer twice with ice-cold PBS and
the cells were then lysed in TNN buffer. The whole-cell
lysates were immunoprecipitated with pooled sera from
infected macaques, and viral proteins were separated by
SDS-PAGE and transferred to nitrocellulose membranes
using a semidry blotter. Cell surface proteins were de-
tected by using streptavidin-conjugated horseradish per-
oxidase and ECL (Amersham Pharmacia Biotech). The
biotin–streptavidin reaction was visualized by exposure
of the nitrocellulose membranes to Hyperfilm ECL film
(Amersham Pharmacia Biotech). After allowing the
biotin–streptavidin reaction to decay for a 3-day period,
the nitrocellulose membranes were then exposed over-
night to Biomax MS-1 films (Eastman Kodak Co.) using
the Transcreen intensifying screen (Eastman Kodak Co.)
to detect total intracellular Env expression. As a control
of the specificity of the cell surface biotinylation reaction,
CV-1 cells expressing rotavirus VP7 protein, a rough
endoplasmic reticulum integral membrane glycoprotein,
were included in the assay.
Reverse transcriptase assays
Reverse transcriptase (RT) assays were performed by
a modification of the procedure of Goff et al. (1981).
Briefly, 10 ml of clarified cell culture supernatant was
dded to 30 ml of a reaction cocktail that gave the
ollowing final concentrations: 50 mM Tris–HCl (pH 8.3),
0 mM NaCl, 5 mM MgCl2, 5 mM dithiothreitol, 0.1%
onidet P-40, 0.5 mM EGTA, 25 mg/ml of poly(rA) z p(dT)10
(Amersham Pharmacia Biotech), and 30–40 mCi/ml
[a-33P]TTP (2000 Ci/mmol; NEN). Reaction mixes were
ncubated at 37°C for 2 h and spotted on DEAE cellulose
embrane filters (NA45-DEAE; Schleicher & Schuell).
he disks were washed three times in 0.5 M Na2HPO4
and once in 95% ethanol and then air-dried. RT levels
were measured by liquid scintillation counting and ex-
pressed as the counts per minute per milliliter of culture
supernatant. All assays were performed in duplicate and
repeated a minimum of two times.Single-cycle infectivity assays
Three micrograms of an env-minus pNL4-3 derivative
[kindly provided by John West (University of Alabama at
Birmingham)] and 3 mg of the various pCDNA-based SIV
Env expression plasmids described above were cotrans-
fected into 293T cells (grown in 60-mm-diameter plates)
by using FuGENE6 transfection reagent (Roche Molecu-
lar Biochemicals). After 48 h transient expression, culture
supernatants were collected and filtered through a 0.45-
mm-pore filter, and the RT levels were determined for
each sample as described above. The RT-normalized
supernatants were used to infect 4 3 104 HeLa-CD4-
CCR5/LTR-b-gal cells in 24-well dishes in duplicate es-
sentially as described by Kimpton and Emerman (1992).
Two days after infection, cells were fixed with PBS con-
taining 1% formaldehyde and 0.2% glutaraldehyde at
room temperature for 5 min and then scored for blue foci
formation after staining with X-Gal (5-bromo-4-chloro-3-
indolyl b-D-galactoside). Virus entry was quantitated as
the total number of blue cells per well by first counting
the number of blue cells in at least ten nonoverlapping
fields in each of the two wells. The average number of
blue cells per field was multiplied by the total number of
fields per well, and the result referred to the number of
blue cells obtained with the SIV wild-type env gene
construct considered as 100%.
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